involved in the action of peptide hormones, startling in its breadth of coverage. Professor Catt came armed with no less than 6 other seminars -a remarkable achievement. The greatest demand was for those on angiotensin and aldosterone, as well as those on the gonadotrophin-releasing hormones. He had detailed laboratory discussions with between 5 and 12 endocrine investigators each day, and all remarked on his perspicacity and helpfulness in discussing their research. Professor Catt proved to be indefatigable, despite what a distinguished British professor described as 'an itinerary for his destruction', and the educational value of his visits to young British researchers proved immense. Perhaps his only moments of peace and quiet were on a train, or when staying at the Domus Medica. He was, of course, entertained by the Clinical Endocrinology Trustees and also by the officers of the Section of Endocrinology.
The value of such visits, however, is not just oneway, and is well exemplified by Professor Catt's remark to me that he had not previously realized how well focused is British endocrine research, nor how diverse. British endocrinology and the Section of Endocrinology in particular express their gratitude to Professor Catt and the Trustees for making such a marvellous visit possible.
CWBurke

Honorary Secretary Section of Endocrinology
Forthcoming events
People on the Margins of Society: Strategies against Exclusion 14th WSW Regional Symposium, 20-25 September 1987in Rome Topics for discussion will include: forms and perceptions of social marginalization; circumstances under which it persists and its reproduction processes; public policies and strategies aimed at fighting it, including the efforts of voluntary organizations, volunteers and self-help groups. 
Letters to the Editor
Preference is given to letters commenting on contributions published recently in the JRSM. They should not exceed 400 words and should be typed double-spaced.
Autologous blood transfusion
Sir, In the editorial on this subject (May JRSM, p 266)Dr Parker-Williams discusses the fate of blood collected for autologous transfusion but not required by the donating patient. He examines the possibility that this blood could be available for other patients and proposes that regional transfusion centres could be involved in undertaking necessary testing.
A Working Party of the Regional Transfusion Directors' Committee has examined this possibility as part of the preparation of Guidelines for Autologous Transfusion. It was recognized that many patients being considered for autologous transfusion would not fully satisfy the criteria for blood donation as NBTS blood donors. Because of this and because of the logistic problems envisaged in testing and labelling donations which were collected and stored outside by the Regional Transfusion Centre, it was agreed that blood not required by the donating patient could not be offered to other patients. If appropriate tests for HBsAg and HIV on the donation were negative, such blood could be used for laboratory purposes, otherwise unused blood should be discarded. D LEE
Chairman, RTD Working Party on Guidelines for Autologous Transfusion, Lancaster
Sir, DrJ Parker-Williams' enthusiasm for autologous blood support services (May JRSM, p 266)is, I'm sure, shared in principle by many of the haematologists who would be called upon to provide these services. Encouragement for the use of autologous blood is to be found in the draft report of the Working Party set up by the Regional Directors' Committee of the National Blood Transfusion Service", whose recommendations aim to ensure the same high level of safety demanded of homologous blood transfusion practice.
Most haematologists are, however, reluctant to provide autologous blood facilities because they have neither the staff nor the funds to support a properly organized service. It should come as no surprise that realistic attempts to cost the exercise in established practices have often found it to be similar to the provision of donor blood": it is a labour-intensive procedure which demands its own distinctive documentation, storage facilities and administrative protocol. Many doctors, in their enthusiasm to undertake eminently worthwhile projects, are apt to underestimate the cost of their activities which might otherwise be considered prohibitive. It is a matter of great concern that the paper from St Thomas' Hospital' should draw such an improbable contrast between the costs of donor and autologous blood. On a point of fact, I know of no manufacturer who supplies a blood collection pack for as little as £1. Moreover, I know of no orthopaedic surgeon who equates the cost of a total hip replacement with that of the prosthesis.
I am enthusiastic about the prospects for autologous blood services and I have no doubt that, in time, they will be commonplace. But there can be no halfmeasures with autologous blood programmes. To provide a safe and effective service will not be cheap. G N SMITH
Consultant Haematologist
Guy's Hospital, London References Soc Med 1987; 80:284-5 Hypotension and blood loss Sir, I read with interest Dr Wittmann's paper 'Blood loss associated with uncemented total hip replacement: hypotension does not affect blood loss' (April JRSM, p 213) and would like to make the following points.
Firstly, there are a number of criticisms of the construction of this study which raise doubts about the validity of the statistical analysis. There is no mention of the cause of the hypotension in the 27 test patients and this could, therefore, have been caused by an independent factor which also affected the blood loss. In addition, the difference in size of the two groups makes adequate analysis of Student's t test questionable, especially as the cases were selected rather than randomized and the spread of values for blood loss unlikely to be of normal distribution.
Secondly, Dr Wittmann states that he intended to undertake a randomized prospective study to test his hypothesis but, as his retrospective data failed to show a significant advantage, he felt this was unethical. Surely the whole reason for undertaking a prospective, well documented study is that retrospective analysis-of data is not capable, as this study demonstrates, of providing the answer. Not to undertake a well controlled study simply because a pilot study of inferior validity failed to provide the required results is against the basic principles of research. Unfortunately, a large amount of past clinical practice has been based on such retrospective studies, much of which is now being questioned by properly controlled trials.
Thirdly, the author seems to indicate that reduction in blood loss is the main reason for hypotension during orthopaedic operations and I would disagree with this. The risks associated with lowering the blood pressure in elderly people are far greater than those associated with blood loss and transfusion. It therefore seems illogical to lower the blood pressure solely for the purpose of reducing blood loss. Hypotension is indicated when a reduction in bleeding at the operation site is required to improve exposure, thereby permitting delicate surgery to be undertaken in a bloodless field. It is for this reason that its use is popular in neurosurgical procedures both on the spine and intracranially. In total hip replacement a bloodless field is not necessary for the adequate performance of the operation and, therefore, the use of Journal of the Royal Society of Medicine Volume 80 September 1987 597 hypotension in this type of surgery is not required, regardless of its effect on blood loss. Finally, despite the above criticisms, I would like to add my support to the final conclusion drawn by Dr Wittmann. Hypotensive anaesthesia should not be used in patients undergoing total hip replacement. It is very easy for a surgeon during a difficult operation, when faced with a bloodier than average operation site, to blame the anaesthetist rather than his own surgical technique, and I feel this practice should be discouraged. I do not, however, think that the data contained in this paper are of sufficient quality to substantiate this conclusion. Sir, I did, in fact, suggest the reason for the hypotension occurring in the 27 patients. It is unlikely that it could have been caused by an independent factor which could have affected the blood loss as all of the patients were treated in exactly the same way.
As to the size of the two groups, the first draft of my manuscript submitted to the JRSM compared the 27 hypotensive patients with 27 other patients in the series who were carefully matched. The referee for the JRSM commented that: 'The method of matching patients between hypotensive and normotensive groups introduces bias ... the correct comparison would be between the 27 hypotensive patients and the 216 normotensive patients'. Interestingly, the same results as reported were found in the matched groups.
Mr Wilde states that: 'Not to undertake a well controlled study ... is against the basic principles of research'. I feel strongly, however, that undertaking a trial in which 'required results' are necessary is very much against the basic principles of research.
With my knowledge of the retrospective findings, it would have been wrong of me to put a case to the hospital ethical committee who would have been duty-bound to refuse permission for a randomized trial. I am surprised that Mr Wilde should suggest that such a trial be conducted as he states that, 'lowering the blood pressure in elderly patients is dangerous', and that 'Hypotensive anaesthesia should not be used in patients undergoing total hip replacement' (no evidence or reasons given). To the contrary, hypotensive anaesthesia has been advocated in many papers (I referred to 5 in my paper) as a useful means of reducing blood loss in THR surgery.
Finally, I certainly did not suggest that reduction in blood loss is the main reason for hypotension during THR but rather that, as there was no advantage in terms of blood loss, hypotension should be strictly avoided.
F W WITTMANN
Consultant Anaesthetist East Surrey Hospital, Redhill
Porokeratosis and immunosuppression
Sir, We were interested to read the case report by Tatnall and Sarkany who describe porokeratosis of Mibelli in an immunocompromised patient (March JRSM, p 180). They cite several other reports in the literature and conclude that there is an association between porokeratosis and immunosuppression, although it seems to be rare.
